Delivery Order SPE2DE21D7010-SPE2D626F05EQ
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $8,427 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 3, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment pricing and involves no set-aside designation, indicating open market competition. The award covers SIMPLIFY spinal surgery products...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- Nuvasive, Inc. has been awarded a $37,861.56 delivery order by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency supporting Department of Defense and Veterans Affairs healthcare operations. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 18, 2025, and involves the delivery of specialized spinal medical technologies and surgical equipment to support military and veteran healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $4,346 fixed-price delivery order with economic price adjustment (FPEA) by the Defense Logistics Agency (DLA) Medical Supply Chain on November 26, 2025, with a completion date of January 5, 2026. This delivery order, issued without set-aside designation, represents a competitive open-market procurement for specialized spinal surgical products and services to support...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a delivery order award valued at $8,138.78 from the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of January 2, 2026. This fixed-price delivery order with economic price adjustment pricing will be fulfilled at Nuvasive's San Diego facility and involves the supply of LEVERAGE LFS spinal medical devices and related surgical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a delivery order award valued at $3,263.33 from the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This fixed-price contract with economic price adjustment delivers MAXCESS spinal surgical products and related medical devices to support federal healthcare operations. The award carries no set-aside...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F05EQDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,033.55 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026, with an ultimate completion date of February 3, 2026. The contract is structured as a firm fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Nuvasive's successful competition in open market procurement. The award supports the delivery of specialized spinal medical devices and surgical products to Department of Defense and Department of Veterans Affairs healthcare facilities located in San Diego, California. This delivery order represents a continuation of Nuvasive's substantial federal contract portfolio with DLA Medical Supply Chain, through which the company supplies an extensive range of spinal fusion devices, interbody implants, bone graft materials, surgical instruments, and related technologies. The award is issued under an $8 million Blanket Purchase Agreement with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027, which streamlines procurement and enables rapid ordering of Nuvasive's comprehensive spinal technology portfolio across military and veteran healthcare systems. Nuvasive's delivery order completions typically occur within weeks to months, reflecting the urgent medical supply requirements of the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 1/12/26 |